Podiatrist · Lecanto, FL
NPI
1811963473
Since 2006
Specialty
Podiatrist
Code 213E00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2385 N Lecanto Hwy
Lecanto, FL, 34461
Phone (352) 746-0077
Groups this clinician bills Medicare through
Medicare paid, 2024
$326K
16,570 services
Medicare patients, 2024
1,327
Average age 76
Drug cost, 2024
$40K
1,823 prescriptions
Company payments, 2024
$32.95
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kenneth P Pritchyk was code J1010 (injection, methylprednisolone acetate, 1 mg), 9,523 times for 149 patients. In total Kenneth P Pritchyk billed 16,570 services in 61 codes, and Medicare paid $326K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-08-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 9,523 | 149 | $0.10 | $967 |
| G0127 Trimming of dystrophic nails, any number | Office | 1,520 | 490 | $8.66 | $13K |
| 11056 Removal or Shaving of Skin Growth | Office | 1,396 | 457 | $54.75 | $76K |
| 99213 Office E&M - Established | Office | 906 | 600 | $63.54 | $58K |
| 99203 Office E&M - New | Office | 457 | 457 | $70.38 | $32K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 397 | 191 | $0.09 | $34.3 |
| 11721 Nail Procedure | Office | 394 | 160 | $31.38 | $12K |
| 73620 X-ray - Lower Extremity | Office | 380 | 268 | $19.01 | $7,224 |
| 11042 Debridement | Office | 346 | 79 | $93.85 | $32K |
| 20550 Musculoskeletal | Office | 329 | 186 | $42.48 | $14K |
| 17000 Destruction Skin Lesion | Office | 167 | 92 | $45.21 | $7,549 |
| J1030 Injection, methylprednisolone acetate, 40 mg | Office | 96 | 70 | $3.58 | $344 |
| 97597 Debridement | Office | 85 | 55 | $69.25 | $5,886 |
| 99221 Hospital E&M - Initial | Facility | 74 | 64 | $64.40 | $4,765 |
| 73600 X-ray - Lower Extremity | Office | 62 | 49 | $22.31 | $1,384 |
By year: 2022 $336K for 7,245 services; 2023 $334K for 7,132 services; 2024 $326K for 16,570 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kenneth P Pritchyk prescribed most often to Medicare patients was Gabapentin, with 363 prescriptions and refills. In total Kenneth P Pritchyk wrote 1,823 Medicare prescriptions that cost $40K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 363 | 604 | 127 | $5,297 |
| Terbinafine Hcl Generic | 309 | 825 | 283 | $6,563 |
| Cephalexin Generic | 167 | 167 | 133 | $1,336 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 155 | 155 | 99 | $1,417 |
| Methylprednisolone Generic | 142 | 142 | 110 | $1,120 |
| Pregabalin Generic | 123 | 188 | 39 | $6,841 |
| Duloxetine Hcl Generic | 78 | 156 | 26 | $1,736 |
| Doxycycline Monohydrate Generic | 67 | 67 | 49 | $1,153 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 46 | 54 | 25 | $708 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 39 | 39 | 19 | $564 |
| Tramadol Hcl Generic | 38 | 38 | 15 | $173 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 33 | 33 | 24 | $231 |
| Clindamycin Hcl Generic | 29 | 31 | 24 | $359 |
| Meloxicam Generic | 28 | 32 | 11 | $151 |
| Ciprofloxacin Hcl Generic | 27 | 27 | 20 | $296 |
Brand drugs: 34 claims; generic drugs: 1,789 claims; opioid claims: 211.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Kenneth P Pritchyk $32.95 ($32.95 in general payments such as food, travel and fees) from 2 companies. The largest payer was ConvaTec Inc. with $19.31.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.